Specifically, CLL cells express inhibitory surface molecules from B7 and TNF-receptor families, namely CD200, CD274 (PD-L1), CD276 and CD270 which are implicated in synapse formation defects in both autologous and allogeneic T cells, suggesting a novel evasion mechanism (61). The gene discussed is CD274; the disease is B-cell chronic lymphocytic leukemia.